Dynorphin and Opioid Peptides Reduce Pain When Injected into the Brain in Rats
Dynorphin A and several other opioid peptides produced dose-dependent, naloxone-reversible pain relief when administered directly into rat brains, confirming their role as natural painkillers.
Quick Facts
What This Study Found
Dynorphin A produced dose-related, naloxone-reversible analgesia via intracerebroventricular injection, confirming its function as an endogenous opioid painkiller acting through kappa receptors.
Key Numbers
How They Did This
Male Sprague-Dawley rats were surgically implanted with brain ventricle cannulas. After recovery, they received injections of dynorphin A or other opioid peptides, and pain response was measured using a cold-water tail-flick assay at -10°C.
Why This Research Matters
This study provided key evidence that dynorphin and related opioid peptides are natural painkillers in the brain, advancing understanding of how the body's endogenous opioid system manages pain.
The Bigger Picture
Understanding how natural opioid peptides like dynorphin relieve pain has been fundamental to developing targeted pain therapies that might work through specific receptor subtypes with fewer side effects than traditional opioids.
What This Study Doesn't Tell Us
This was an animal study with direct brain injection, a route not applicable to humans. The cold-water tail-flick test measures a specific type of acute pain that may not represent chronic pain conditions.
Questions This Raises
- ?Could kappa receptor-targeted therapies provide pain relief with fewer addiction risks than traditional opioids?
- ?How do these findings translate to pain management strategies in humans?
Trust & Context
- Key Stat:
- Dose-dependent analgesia Dynorphin A (1-17) produced increasing pain relief at higher doses, fully reversible by the opioid blocker naloxone
- Evidence Grade:
- Preliminary animal study using direct brain injection in rats. Demonstrates a clear mechanism but is far removed from practical human application.
- Study Age:
- Published in 1988, this is a foundational study in opioid peptide pharmacology.
- Original Title:
- Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
- Published In:
- The Journal of pharmacology and experimental therapeutics, 246(2), 449-53 (1988)
- Authors:
- Tiseo, P J, Geller, E B, Adler, M W
- Database ID:
- RPEP-00095
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is dynorphin?
Dynorphin is a naturally produced opioid peptide in the brain that acts primarily on kappa opioid receptors. It's one of the body's endogenous painkillers, alongside beta-endorphin and enkephalins.
What does 'naloxone-reversible' mean?
Naloxone is a drug that blocks opioid receptors. When naloxone reversed dynorphin's pain-relieving effect, it proved the analgesia was specifically mediated through opioid receptors rather than some other mechanism.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00095APA
Tiseo, P J; Geller, E B; Adler, M W. (1988). Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.. The Journal of pharmacology and experimental therapeutics, 246(2), 449-53.
MLA
Tiseo, P J, et al. "Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.." The Journal of pharmacology and experimental therapeutics, 1988.
RethinkPeptides
RethinkPeptides Research Database. "Antinociceptive action of intracerebroventricularly administ..." RPEP-00095. Retrieved from https://rethinkpeptides.com/research/tiseo-1988-antinociceptive-action-of-intracerebroventricularly
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.